We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Psource | LSE:PSD | London | Ordinary Share | GG00B236KR59 | ORD NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.75 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMPSD
RNS Number : 7087Q
PSource Structured Debt Limited
08 November 2012
8/11/2012
PSource Structured Debt Limited
NAV for September 2012
The NAV per share for PSource Structured Debt Limited (PSD) as at 30 September 2012 is $0.6898 (42.67p), representing a total return of +0.67% for September 2012. At month end there were 59,564,681 shares in issue and the total NAV was $41,088,891. PSD is in a managed wind down.
As at 30 September 2012, the Company had a cash balance of $91,535. The Company subsequently received an additional $628,696 from the sales of its BioDelivery Sciences International, Inc. ("BDSI") warrant position (after transaction costs).
As at 30 September 2012, the portfolio included material investments in 8 companies. The maximum position in any company was 71.19% of the portfolio (being the holding in Parabel, held through a holding company PetroTech Holdings, Inc).
On 23 October 2012, the Company sold its remaining BDSI warrant position for $178,058. Although this represents a discount to the position's 31 August 2012 valuation of $241,290, based upon 22 October 2012 closing share price, the remaining warrants then had an intrinsic value of $39,742. In total, the Company received $628,696 from the sale of this position. Following this sale, the Company has no material warrant position.
An analysis of the portfolio by geography and industry as at 30 September 2012 is set out below:
US State Debt/ Warrant/ No. of or Country Total Loan note Equity companies $ $ $ ------------ ------------------ ------------------- ---------------------- --------------------- AZ 91,969 91,294 675 1 Canada 3,646,631 3,646,631 - 1 CO 251,279 251,250 29 1 FL 33,726,223 11,286,177 22,440,047 3 IL 1,973,264 1,973,264 - 1 TX 592,350 592,350 - 1 40,281,716 17,840,965 22,440,751 8 ================== =================== ====================== ===================== Debt/ Warrant/ No. of Industry Total $ Loan note Equity companies $ $ ------------ ---------------------- -------------------- ----------------------- ----------------- Biotech 5,048,655 4,087,667 960,988 2 Computers 251,279 251,250 29 1 Consulting 1,973,264 1,973,264 - 1 Industrial 592,350 592,350 - 1 Renewable Energy 28,677,569 7,198,510 21,479,059 1 Security 3,646,631 3,646,631 - 1 Technology 91,969 91,294 675 1 40,281,716 17,840,965 22,440,751 8 ====================== ==================== ======================= =================
Note: single company investments with a current valuation below $500 are not considered in the company investment count.
A further analysis of the Company's portfolio and balance sheet as at 30 September 2012 is set out below:
Balance sheet Analysis ----------------------------------- ------------ ------------ ----------- Loans % of Gross Gross Debt $12,747,870 31.65% Less Impairment -$2,105,414 -5.23% ------------ Net Debt (4) $10,642,455 26.42% PetroTech Preferred (3) $7,198,510 17.87% Total Loans $17,840,965 44.29% ------------ Equity PetroTech Common (3) $21,479,059 53.32% Other Equities $961,692 2.39% Total Equity $22,440,751 55.71% ------------ Gross Portfolio $40,281,716 100.00% Cash $91,535 0.23% Other Debtors/Liabilities/Accrued Expenses $715,640 1.78% NAV $41,088,891 102.00% =================================== ============ ============ ===========
Monthly total return performance since inception is set out below(5) :
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec YTD ------ ------- ------- ------- ------- ------- -------- ------- ------- ------- ------- ------- -------- -------- 2012 2.27% -0.53% -1.06% -0.39% -0.38% -41.74% 0.25% -5.66% 0.67% -44.60% 2011 -0.97% -0.95% -0.94% -1.73% -0.29% -3.08% -0.83% -0.96% -0.55% -0.39% -1.22% -21.79% -30.64% 2010 5.85% -0.11% 1.77% -2.02% -2.57% -2.17% -1.16% -4.29% 1.08% 0.72% -0.22% -1.30% -4.68% 2009 4.99% -5.25% 2.95% 1.16% 3.76% 1.66% 1.37% -0.13% -0.50% 1.47% 4.20% 4.70% 21.86% 2008 0.55% 1.87% 2.05% 1.49% 1.73% 0.72% 1.41% 2.43% 0.03% -2.14% -4.78% 0.37% 5.63% 2007 -0.38% 1.19% 2.49% 1.95% 1.64% 7.06%
Notes:
1. Penny warrants are warrants with a strike price of approximately 1 cent per share. These are held at a 7% discount to realisable value.
2. Standard warrants are held at a 30% discount to a Black-Scholes valuation. Where the 260-day volatility provided by Bloomberg exceeds 100%, 100% is used as the input to the Black-Scholes model.
3. The Company's holding in Parabel is based on an effective share price of $4.24.
4. Debt is valued monthly with advice from the Company's independent valuation agent, MountainView (formerly known Clayton IPS), and is held at par less appropriate impairment provisions.
5. Monthly returns based on Sterling returns until December 2008 and Dollar returns thereafter.
Further information is available on the Company's website: www.psourcestructureddebt.com.
Contact:
Soondra Appavoo
PSource Capital Limited
020 3327 5251
This information is provided by RNS
The company news service from the London Stock Exchange
END
NAVGMMGMNRFGZZM
1 Year Psource Chart |
1 Month Psource Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions